Sectors
CSBR
Champions Oncology, Inc.
6.16
1 x 6.07
2 x 6.16
bid
ask
+
0.06
0.98%
10:00 AM
timesize
| Ytd | -10.85% | |
| 1y | -21.53% |
6.16
day range
6.16
5.50
52 week range
8.74
| Open | 6.16 | Prev Close | 6.10 | Low | 6.16 | High | 6.16 | Mkt Cap | 84.71M |
| Vol | 128.00 | Avg Vol | 8.61K | EPS | -0.16 | P/E | -38.12 | Forward P/E | 42.68 |
| Beta | 0.39 | Short Ratio | 20.86 | Inst. Own | 49.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-12 | 50-d Avg | 6.04 | 200-d Avg | 6.32 | 1yr Est | 8.00 |
| Income Statement | |||
| Total Revenue | 16.56M | ||
| Revenues (USD) | 16.56M | ||
| Cost of Revenue | 8.83M | ||
| Gross Profit | 7.73M | ||
| Operating Expenses | 8.00M | ||
| Research and Development Expense | 2.27M | ||
| Selling, General and Administrative Expense | 5.64M | ||
| Operating Income | -276.00K | ||
| Income Tax Expense | 42.00K | ||
| Net Income | -279.00K | ||
| Net Income Common Stock | -279.00K | ||
| Net Income Common Stock (USD) | -279.00K | ||
| Consolidated Income | -279.00K | ||
| Earnings per Basic Share | -0.02 | ||
| Earnings per Basic Share (USD) | -0.02 | ||
| Earnings per Diluted Share | -0.02 | ||
| Earning Before Interest & Taxes (EBIT) | -237.00K | ||
| Earning Before Interest & Taxes (USD) | -237.00K | ||
| Weighted Average Shares | 13.89M | ||
| Weighted Average Shares Diluted | 13.89M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.13M | ||
| Cash and Equivalents (USD) | 7.13M | ||
| Trade and Non-Trade Receivables | 12.07M | ||
| Current Assets | 20.18M | ||
| Property, Plant & Equipment Net | 7.73M | ||
| Total Assets | 28.45M | ||
| Debt Current | 1.53M | ||
| Total Debt | 4.89M | ||
| Current Liabilities | 20.68M | ||
| Debt Non-Current | 3.37M | ||
| Total Liabilities | 24.07M | ||
| Accumulated Retained Earnings (Deficit) | -80.40M | ||
| Shareholders Equity | 4.28M | ||
| Shareholders Equity (USD) | 4.28M | ||
| Assets Non-Current | 8.26M | ||
| Total Debt (USD) | 4.89M | ||
| Deferred Revenue | 10.00M | ||
| Goodwill and Intangible Assets | 335.00K | ||
| Liabilities Non-Current | 3.39M | ||
| Trade and Non-Trade Payables | 5.73M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 341.00K | ||
| Net Cash Flow from Financing | -36.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.39M | ||
| Capital Expenditure | -14.00K | ||
| Issuance (Purchase) of Equity Shares | 3.00K | ||
| Issuance (Repayment) of Debt Securities | -39.00K | ||
| Net Cash Flow from Investing | -14.00K | ||
| Net Cash Flow from Operations | -1.34M | ||
| Share Based Compensation | 423.00K | ||